Stop Addiction Stigma
Status
Conditions
Treatments
Study type
Funder types
Identifiers
Details and patient eligibility
About
This clinical trial evaluates the impact of a Stop Addiction Stigma (SAS) training workshop with a short description of the conditions related to addiction (vignettes) on stigmatizing attitudes toward individuals with substance abuse disorders. Reviews have shown that patients with substance abuse disorders have experienced negative attitudes from their health care providers. Negative attitudes may lead to less involvement from the provider and the patient and may lead to less effective care. Using case vignettes with a SAS workshop may be an effective method to help people learn about addiction, reduce the stigma toward addiction and improve the quality of health care.
Full description
PRIMARY OBJECTIVE:
I. To describe the impact of SAS training on participants' responses to people with a substance impairment.
SECONDARY OBJECTIVES:
I. To evaluate the feasibility of stigma training workshops on stigmatizing attitudes health care personnel.
II. To explore the maintainability of responses over time. III. To explore relationships between language and stigmatizing attitudes.
OUTLINE: Participants are randomized to 1 of 6 group case vignettes.
GROUP A (CHRONICALLY RELAPSING BRAIN DISEASE): Participants view the chronically relapsing brain disease vignette and attend a SAS workshop on study.
GROUP B (BRAIN DISEASE): Participants view the brain disease vignette and attend a SAS workshop on study.
GROUP C (DISEASE): Participants view the disease vignette and attend a SAS workshop on study.
GROUP D (ILLNESS): Participants view the illness vignette and attend a SAS workshop on study.
GROUP E (DISORDER): Participants view the disorder vignette and attend a SAS workshop on study.
GROUP F (PROBLEM): Participants view the problem vignette and attend a SAS workshop on study.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria:
- Employee of Ohio State University Wexner Medical Center (OSUWMC)
- Age ≥ 18 years
- Participants must be able to read and comprehend survey items
Trial design
Primary purpose
Allocation
Interventional model
Masking
93 participants in 6 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal